Literature DB >> 1996644

Intestinal motility changes in rats after enteric serotonergic neuron destruction.

V M Piñeiro-Carrero1, M H Clench, R H Davis, J M Andres, D A Franzini, J R Mathias.   

Abstract

The myenteric plexus consists of several subpopulations of morphologically and chemically distinct neurons known to contain a variety of peptides and amines, one of which is serotonin (5-hydroxytryptamine). These neurons are considered essential for nerve-to-nerve transmission. In the present study, we investigated the effect of 5,6- and 5,7-dihydroxytryptamine (5,6-DHT; 5,7-DHT), indoleamine neurotoxins that selectively and irreversibly injure the serotonergic neurons of the myenteric plexus. Treatment with 5,6-, or 5,7-DHT caused marked disruption of the activity front of the migrating myoelectric complex (MMC), increased its duration, and decreased its propagation velocity. At higher doses, 5,7-DHT also reduced the slow-wave frequency. Immunohistochemical techniques showed that tissue from rats treated with 5,7-DHT was depleted of serotonin-like immunoreactivity within the myenteric plexus neurons. Reserpine also caused motility and immunohistochemical changes similar to those induced by the two neurotoxins. Therefore, destruction of enteric serotonergic neurons disrupts the MMC. These studies support the cellular concepts that serotonergic neurons function as interneurons in the myenteric plexus, modulating and processing the neural stimuli, and that serotonin is an important neurotransmitter in the small intestine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1996644     DOI: 10.1152/ajpgi.1991.260.2.G232

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

Review 1.  Serotonergic modulating drugs for functional gastrointestinal diseases.

Authors:  Robin Spiller
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

2.  Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat.

Authors:  J X Zhu; X Y Zhu; C Owyang; Y Li
Journal:  J Physiol       Date:  2001-02-01       Impact factor: 5.182

3.  Divergent changes to muscarinic and serotonergic signalling following colitis.

Authors:  R W Wells; M G Blennerhassett
Journal:  Gut       Date:  2005-07-13       Impact factor: 23.059

4.  Actions of the 5-hydroxytryptamine 1 receptor agonist sumatriptan on interdigestive gastrointestinal motility in man.

Authors:  J Tack; B Coulie; A Wilmer; T Peeters; J Janssens
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

5.  5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake.

Authors:  D A Gorard; G W Libby; M J Farthing
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

6.  Effects of ghrelin on interdigestive contractions of the rat gastrointestinal tract.

Authors:  Hiroshi Taniguchi; Hajime Ariga; Jun Zheng; Kirk Ludwig; Toku Takahashi
Journal:  World J Gastroenterol       Date:  2008-11-07       Impact factor: 5.742

7.  Maternal Prepregnancy 5-Hydroxytryptamine Exposure Affects the Early Development of the Fetus.

Authors:  Yu Han; Meng Zhang; Jiahui Duan; Leyi Li; Jinge Du; Hui Cheng; Sheng Zhang; Yanhui Zhai; Xinglan An; Qi Li; Xueming Zhang; Ziyi Li; Bo Tang
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

8.  Mechanism of ghrelin-induced gastric contractions in Suncus murinus (house musk shrew): involvement of intrinsic primary afferent neurons.

Authors:  Anupom Mondal; Sayaka Aizawa; Ichiro Sakata; Chayon Goswami; Sen-ichi Oda; Takafumi Sakai
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.